Sands Capital Management, LLC Dexcom Inc Transaction History

Sands Capital Management, LLC

$27.6 Billion
Q1 2025

A detailed history of Sands Capital Management, LLC transactions in Dexcom Inc stock. As of the latest transaction made, Sands Capital Management, LLC holds 10,414,156 shares of DXCM stock, worth $884 Million. This represents 2.57% of its overall portfolio holdings.

Number of Shares

10,414,156

Previous 11,109,501 6.26%

Holding current value

$884 Million

Previous $864 Million 17.69%

% of portfolio

2.57%

Previous 2.73%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	SELL	$67.74 - $90.75 $47.1 Million - $63.1 Million	-695,345 Reduced 6.26%	10,414,156 $711 Million
Q4 2024 Feb 13, 2025	BUY	$65.68 - $81.01 $51.9 Million - $64 Million	790,303 Added 7.66%	11,109,501 $864 Million
Q3 2024 Nov 13, 2024	SELL	$64.0 - $116.06 $18.4 Million - $33.3 Million	-287,305 Reduced 2.71%	10,319,198 $692 Million
Q2 2024 Aug 13, 2024	SELL	$110.31 - $140.45 $32 Million - $40.8 Million	-290,261 Reduced 2.66%	10,606,503 $1.2 Billion
Q1 2024 May 14, 2024	SELL	$114.22 - $140.1 $475 Million - $583 Million	-4,162,042 Reduced 27.64%	10,896,764 $1.51 Billion
Q4 2023 Feb 13, 2024	BUY	$75.49 - $124.16 $106 Million - $174 Million	1,398,136 Added 10.23%	15,058,806 $1.87 Billion
Q3 2023 Nov 14, 2023	BUY	$86.06 - $137.93 $48 Million - $76.9 Million	557,543 Added 4.26%	13,660,670 $1.27 Billion
Q2 2023 Aug 15, 2023	SELL	$112.47 - $130.98 $71.5 Million - $83.3 Million	-635,841 Reduced 4.63%	13,103,127 $1.68 Billion
Q1 2023 May 12, 2023	SELL	$104.0 - $122.92 $185 Million - $218 Million	-1,775,467 Reduced 11.44%	13,738,968 $1.6 Billion
Q4 2022 Feb 13, 2023	SELL	$84.98 - $122.67 $100 Million - $145 Million	-1,178,883 Reduced 7.06%	15,514,435 $1.76 Billion
Q3 2022 Nov 09, 2022	SELL	$76.35 - $94.18 $92.3 Million - $114 Million	-1,208,895 Reduced 6.75%	16,693,318 $1.34 Billion
Q2 2022 Aug 12, 2022	BUY	$67.99 - $132.89 $932 Million - $1.82 Billion	13,712,968 Added 327.34%	17,902,213 $1.33 Billion
Q1 2022 May 13, 2022	BUY	$94.08 - $130.2 $99.8 Million - $138 Million	1,060,655 Added 33.9%	4,189,245 $2.14 Billion
Q4 2021 Feb 11, 2022	SELL	$129.87 - $162.82 $25.4 Million - $31.9 Million	-195,778 Reduced 5.89%	3,128,590 $1.68 Billion
Q3 2021 Nov 03, 2021	BUY	$106.71 - $143.18 $30.6 Million - $41.1 Million	287,092 Added 9.45%	3,324,368 $1.82 Billion
Q2 2021 Aug 16, 2021	BUY	$80.99 - $107.93 $8.16 Million - $10.9 Million	100,774 Added 3.43%	3,037,276 $1.3 Billion
Q1 2021 May 12, 2021	BUY	$84.79 - $104.74 $54.7 Million - $67.6 Million	645,568 Added 28.18%	2,936,502 $1.06 Billion
Q4 2020 Feb 16, 2021	SELL	$78.0 - $104.5 $3.18 Million - $4.26 Million	-40,724 Reduced 1.75%	2,290,934 $847 Million
Q3 2020 Nov 16, 2020	BUY	$95.51 - $112.95 $46.9 Million - $55.5 Million	490,992 Added 26.67%	2,331,658 $961 Million
Q2 2020 Aug 11, 2020	BUY	$62.68 - $105.34 $84.2 Million - $141 Million	1,342,996 Added 269.86%	1,840,666 $746 Million
Q1 2020 May 14, 2020	BUY	$47.79 - $75.63 $23.8 Million - $37.6 Million	497,670 New	497,670 $134 Million

Others Institutions Holding DXCM

# of Institutions

1,084

Shares Held

362M

Call Options Held

5.4M

Put Options Held

4.3M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $32.8B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sands Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sands Capital Management, LLC with notifications on news.

Account

Sands Capital Management, LLC Dexcom Inc Transaction History